Shield
FDA-approved blood test for colorectal cancer screening.
+ What's included
- Blood-based screening test
- Analyses cell-free DNA from a blood sample
🇺🇸Precision oncology company making blood tests for cancer screening, monitoring and treatment selection.
Guardant Health is a precision oncology company based in Palo Alto, California. It provides blood and tissue tests for cancer screening, for monitoring early-stage cancer and for guiding treatment in advanced cancer. The company was founded in 2012 and is listed on Nasdaq under the ticker GH. It has offices in the United States, Singapore, Japan, China, India and Israel.
FDA-approved blood test for colorectal cancer screening.
Liquid biopsy and tissue tests that help inform treatment decisions in advanced cancer.
Blood test that uses circulating tumor DNA to detect cancer at the molecular level.
Doctors order its tests for patients with early or advanced cancer and for people eligible for colorectal cancer screening.
Show your products, customers and traction to founders, investors and partners across 30+ countries.